Adams Diversified Equity Fund’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,700	Closed	-$10.3M	–	106
2025 Q2	$10.3M	Hold	19,700	–	–	0.37%	83
2025 Q1	$12.5M	Sell	19,700 -2,000	-9%	-$1.38M	0.5%	70
2024 Q4	$15.5M	Hold	21,700	–	–	0.58%	58
2024 Q3	$22.8M	Sell	21,700 -10,600	-33%	-$11.8M	0.84%	37
2024 Q2	$33.9M	Hold	32,300	–	–	1.16%	16
2024 Q1	$31.1M	Hold	32,300	–	–	1.1%	23
2023 Q4	$28.4M	Hold	32,300	–	–	1.12%	31
2023 Q3	$26.6M	Buy	32,300 +12,300	+62%	+$9.67M	1.14%	27
2023 Q2	$14.4M	Sell	20,000 -13,500	-40%	-$10.4M	0.6%	70
2023 Q1	$27.5M	Hold	33,500	–	–	1.24%	20
2022 Q4	$24.2M	Buy	33,500 +2,900	+9%	+$2.14M	1.16%	23
2022 Q3	$21.1M	Hold	30,600	–	–	1.05%	28
2022 Q2	$18.1M	Sell	30,600 -14,400	-32%	-$9.36M	0.86%	44
2022 Q1	$31.4M	Buy	45,000 +14,900	+50%	+$9.43M	1.25%	23
2021 Q4	$19M	Hold	30,100	–	–	0.72%	53
2021 Q3	$18.2M	Buy	+30,100	New	+$18.7M	0.72%	57